Spotlight On SMID-Caps: Morningstar's Undervalued Picks [Seeking Alpha]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Seeking Alpha
Play 29min Summary The Morningstar US Small-Mid Cap Moat Focus Index targets undervalued SMID-cap companies with durable competitive advantages, leveraging Morningstar's extensive equity research. Notable investment opportunities include Ionis Pharmaceuticals, CarMax, Norwegian, Zoom, Wynn Resorts, Baxter International, Scotts Miracle-Gro, Global Payments, Sensata Technologies, and Bath & Body Works. Despite near-term challenges, these companies are expected to achieve sustainable profitability and growth, making them attractive buys at current valuations. alexsl/iStock via Getty Images Transcript Brandon Rakszawski, Director of Product Management The Morningstar US Small-Mid Cap Moat Focus Index offers investors exposure to US SMID-cap companies that Morningstar's equity research team believes possess durable competitive advantages and trade at attractive This article was written by VanEck 4.23K Follower s Follow VanEck's mission is to offer investors int
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis to hold fourth quarter and full year 2024 financial results webcastBusiness Wire
- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.MarketBeat
- Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum [Yahoo! Finance]Yahoo! Finance
- Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentumPR Newswire
- Ionis to present at 43rd Annual J.P. Morgan Healthcare ConferencePR Newswire
IONS
Earnings
- 11/6/24 - Beat
IONS
Sec Filings
- 2/13/25 - Form SCHEDULE
- 2/7/25 - Form SCHEDULE
- 2/6/25 - Form 4
- IONS's page on the SEC website